Clinical Trials in Shihezi, China

2 recruiting

Showing 19 of 9 trials

Recruiting
Phase 3

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Chronic Obstructive Pulmonary Disease
Sanofi942 enrolled183 locationsNCT07190209
Recruiting

IMPACT COPD Cohort (China)

Chronic Obstructive Pulmonary Disease (COPD)Multimorbidities
Beijing Chao Yang Hospital10,000 enrolled4 locationsNCT07382986
Recruiting
Phase 3

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

COPD, Chronic Obstructive Pulmonary Disease
AstraZeneca5,000 enrolled917 locationsNCT06283966
Recruiting
Not Applicable

Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System

Ischemic StrokeTransient Ischemic Attack (TIA)
Beijing Tiantan Hospital4,490 enrolled3 locationsNCT06783049
Recruiting
Not Applicable

Efficacy and Safety of Home-based Structured Physical Exercise in Patients With Acute Ischemic Stroke

Acute Ischemic Stroke
Capital Medical University208 enrolled6 locationsNCT07271082
Recruiting
Phase 3

Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)

Acute Ischemic StrokeCerebral Infarction
Capital Medical University1,184 enrolled71 locationsNCT06548971
Recruiting
Phase 4

ASPIrin in Reducing Events in Dialysis ( ASPIRED )

CKD (Chronic Kidney Disease) Stage 5D
Guangdong Provincial People's Hospital9,000 enrolled139 locationsNCT04381143
Recruiting
Phase 3

Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)

Ischemic Stroke, Acute
Beijing Tiantan Hospital1,380 enrolled82 locationsNCT06157502
Recruiting
Phase 3

TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

Asthma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.660 enrolled74 locationsNCT06829784